|
MIS12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.1094237467878E-15 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
5.364800E-01 |
| Stage1-vs-Stage3 |
1.404450E-03 |
| Stage1-vs-Stage4 |
7.396800E-03 |
| Stage2-vs-Stage3 |
6.176400E-03 |
| Stage2-vs-Stage4 |
1.196290E-02 |
| Stage3-vs-Stage4 |
7.819400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.31281660489913E-12 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
8.736400E-01 |
| Caucasian-vs-Asian |
6.902600E-01 |
| AfricanAmerican-vs-Asian |
9.014200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.965800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
4.29850000038812E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.149200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.513990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.986000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.678800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.549800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.073800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.80930000373658E-08 |
| Classical-VS-Follicular |
5.853500E-02 |
| Classical-VS-Other |
8.154400E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
2.20379999804621E-08 |
| Tall-VS-Other |
8.007900E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
6.657200E-01 |
| Follicular-VS-Normal |
1.77224901420914E-12 |
| Other-VS-Normal |
1.71951999999864E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
6.719600E-02 |
|
|
